AmerisourceBergen

Alwood Pharmacy was honored as the recipient of Good Neighbor Pharmacy’s annual Pharmacy of the Year award.

Walgreens Boots Alliance sold shares of AmerisourceBergen common stock through a registered public offering of approximately $1.6 billion. AmerisourceBergen also announced a registered public offering of 10.5 million shares of common stock.

TPG has acquired a majority interest in OneOncology, and AmerisourceBergen has acquired a minority interest in the company.

The two organizations have kicked off their collaboration with the co-creation of a telehealth solution focused on Test to Treat opportunities.

The investment further strengthens AmerisourceBergen’s solutions in specialty.

The new name represents a unified presence that will continue to fuel the company’s ongoing growth strategy and advance its impact across health care.

Walgreens Boots Alliance’s ownership of AmerisourceBergen’s common stock decreased from approximately 20% to 17%.

After the sale, Walgreens Boots Alliance's ownership of AmerisourceBergen’s common stock has decreased from approximately 28.1% to approximately 25.2%.